Merck Study Was For Marketing: Report
The study known as Advantage was intended to get doctors to prescribe the blockbuster painkiller, which was pulled from the market in September 2004, an article published Tuesday in the Annals of Internal Medicine said
The article also said that Merck's marketing division handled both the scientific and...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login